Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose

A large-scale study involving over 600,000 U.S. veterans indicates that GLP-1 drugs, commonly used for weight loss and diabetes, might also help reduce the risk of substance use disorders and improve outcomes for those already dealing with addiction. Individuals on these medications showed a lower likelihood of developing addictions to substances like alcohol, nicotine, and opioids, and those with existing addictions experienced fewer severe outcomes such as overdoses. This suggests a broader therapeutic potential for GLP-1 drugs, which could revolutionize treatment approaches for addiction.